Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Hepatic nerves have a complex role in synchronizing liver metabolism. Here, we used three-dimensional (3D) immunoimaging to explore the integrity of the hepatic nervous system in experimental and human nonalcoholic fatty liver disease (NAFLD). We demonstrate parallel signs of mild degeneration and axonal sprouting of sympathetic innervations in early stages of experimental NAFLD and a collapse of sympathetic arborization in steatohepatitis. Human fatty livers display a similar pattern of sympathetic nerve degeneration, correlating with the severity of NAFLD pathology. We show that chronic sympathetic hyperexcitation is a key factor in the axonal degeneration, here genetically phenocopied in mice deficient of the Rac-1 activator Vav3. In experimental steatohepatitis, 3D imaging reveals a severe portal vein contraction, spatially correlated with the extension of the remaining nerves around the portal vein, enlightening a potential intrahepatic neuronal mechanism of portal hypertension. These fundamental alterations in liver innervation and vasculature uncover previously unidentified neuronal components in NAFLD pathomechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4 NAergic nerve fiber pathology in experimental steatosis (WT + WD) and steatohepatitis (MT + WD) in 3D. (A to F) TH 3D staining of CoD (A and D), WT + WD (B and E), and MT + WD (C and F) samples. Boxed volumes in (A), (B), and (C) [(d′), (e′), and (f′), respectively] are enlarged in (D), (E), and (F), respectively. (G and H) Zoom of proximal (G) and distal (H) TH+ fiber branches in MT + WD. Boxed zones in (C) and (F) [(g′) and (h′), respectively] are enlarged in (G) and (H), respectively. (I to K) Quantification (K) of total TH+ fiber volume in CoD (I) and in MT + WD (J). (L and M) Measurement of liver NA (L) and galanin (M) levels. (N to P) PGP9.5 3D staining in CoD (N) and in MT + WD (O). Boxed zone in (O) [(p′)] is enlarged in (P). *P < 0.05, CoD versus MT + WD; #P < 0.05, WT + WD versus MT + WD. Data expressed as means ± SEM, n = 5 to 7 per group. Scale bar is indicated in each micrograph.](https://figures.cochat.ai/paper-figures/c7e7e7e872fd4dd486ceee1d68589b69/disorganization-and-degeneration-of-liver-sympathetic-innervations-in-figure-4.jpg)

![Fig. 6 Quantification of NAergic nerve fiber degeneration in mouse liver. (A to C) Gradual retraction of distal TH+ nerve endings in WT + WD (B) and in MT + WD (C) versus CoD (A). (A1 to C1) 2D projected pictures from 500-μm-thick virtual rectangles [an example in (A) is indicated with *]. (D and E) Quantification of TH+ fiber ending/corresponding portal vein ending distances [(D); white arrows in (A1) to (C1)] and most distal portal vein ending/organ surface distances [(E); blue arrows in (A1) to (C1)]; n = 5 to 6 per group. (F) Tracing main fiber bundles (diameter > 8 μm). (G to I) Representative examples for traced main NAergic fiber arborizations in entire samples in CoD (G), WT + WD (H), and MT + WD (I). Branching levels are color-coded as indicated in (I). (J) Quantification of main fiber structures; n = 5 to 7 per group. *P < 0.05, CoD versus MT + WD; #P < 0.05, WT + WD versus MT + WD. Data expressed as mean ± SEM. Scale bar is indicated in each micrograph.](https://figures.cochat.ai/paper-figures/69be72e99d2d4c1d95148f0c744bb088/disorganization-and-degeneration-of-liver-sympathetic-innervations-in-figure-6.jpg)
![Fig. 7 SNAP-25b–deficient mice on control diet (MT + CoD) do not show signs of sympathetic axonal degeneration. (A to D) TH 3D staining of WT control diet (WT + CoD) (A and C) and SNAP-25b–deficient on control diet (MT + CoD) (B and D) samples. Boxed volumes in (A) and in (B) [(c′) and (d′), respectively] are enlarged in (C) and (D), respectively. (E) Quantification of total sympathetic fiber volume in MT + CoD versus WT + CoD; n = 5 to 7 per group. (F) Quantification of TH+ fiber ending/corresponding portal vein ending distances in MT + CoD versus WT + CoD (n = 5 per group). (G) Quantification of most distal portal vein ending/organ surface distances in MT + CoD versus WT + CoD (n = 5 per group). (H) Measuring of hepatic NA levels in MT + CoD versus WT + CoD; n = 6 to 9 per group. (I) Quantified results of filament tracing in MT + CoD versus WT + CoD; n = 5 to 7 per group. Data expressed as means ± SEM. Scale bar is indicated in each micrograph.](https://figures.cochat.ai/paper-figures/5a8f3f51bb214462a4242ad7058f754b/disorganization-and-degeneration-of-liver-sympathetic-innervations-in-figure-7.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“given that the liver is primarily innervated by sympathetic nerves, which produce norepinephrine (NE),9,10 and not by parasympathetic nerves,12,13,14”
From B cell-derived acetylcholine promotes liver regeneration by regulating Kupffer cell and hepatic CD8+ T cell function (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neurotransmitters such as acetylcholine (ACh) play a role in LR by stimulating immune cells such as Kupffer cells6,7,8 and by augmenting hepatocyte proliferation.9,10,11”
From B cell-derived acetylcholine promotes liver regeneration by regulating Kupffer cell and hepatic CD8+ T cell function (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149 · cited 2×
“Theodorsson, Effects of 17-estradiol on galanin(1-29)and galanin(1-16)-like immunoreactivities.”
BackgroundCause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Diehl, A. M., & Day, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1503519 · Cited by 1,283 · cited 3×
“NAFLD, often considered as the hepatic manifestation of metabolic syndrome, is usually associated with visceral obesity, insulin resist ance, increased blood pressure, fasting hyperglycemia, type 2 diabetes, and dyslipidemia (2, 3).”
BackgroundMapping of Brain Activity by Automated Volume Analysis of Immediate Early Genes
Renier, N., Adams, E. L., Kirst, C., Wu, Z., Azevedo, R., Kohl, J., Autry, A. E., Kadiri, L., Umadevi Venkataraju, K., Zhou, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.007 · Cited by 918
Bedossa, P., Poitou, C., Veyrie, N., Bouillot, J.-L., Basdevant, A., Paradis, V., Tordjman, J., & Clement, K. (2012) · Hepatology · doi:10.1002/hep.25889 · Cited by 903
Tissue clearing and its applications in neuroscience
Ueda, H. R., Ertürk, A., Chung, K., Gradinaru, V., Chédotal, A., Tomancak, P., & Keller, P. J. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0250-1 · Cited by 609 · cited 1×
“Application of volume imaging technologies is, today, in the front line of system biological studies ( 26 ).”
Backgroundβ2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer
Renz, B. W., Takahashi, R., Tanaka, T., Macchini, M., Hayakawa, Y., Dantes, Z., Maurer, H. C., Chen, X., Jiang, Z., Westphalen, C. B., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.11.007 · Cited by 543
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Takahashi, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15539 · Cited by 486 · cited 3×
“Theodorsson, Effects of 17-estradiol on galanin(1-29)and galanin(1-16)-like immunoreactivities.”
BackgroundPathology of Nonalcoholic Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2007) · American Journal of Clinical Pathology · doi:10.1309/rtpm1py6ygbl2g2r · Cited by 469 · cited 3×
“NAFLD, often considered as the hepatic manifestation of metabolic syndrome, is usually associated with visceral obesity, insulin resist ance, increased blood pressure, fasting hyperglycemia, type 2 diabetes, and dyslipidemia (2, 3).”
BackgroundArvidsson, U., Riedl, M., Elde, R., & Meister, B. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970224)378:4<454::aid-cne2>3.0.co;2-1 · Cited by 435 · cited 1×
“Studies applying VAChT immunohistochemistry did not find cholinergic nerves in rat ( 48 ) or mouse ( 49 ) liver.”
BackgroundAnimal models of non‐alcoholic fatty liver disease: current perspectives and recent advances
Lau, J. K. C., Zhang, X., & Yu, J. (2017) · The Journal of Pathology · doi:10.1002/path.4829 · Cited by 373
Research works printed but not linked: 3
- 10.1002/cphy.c120018 · doi:10.1002/cphy.c120018 · Paper page
- 10.1111/j.1572-0241.1999.01232.x · doi:10.1111/j.1572-0241.1999.01232.x · Paper page
- J. Kehr T. Yoshitake Monitoring brain chemical signals by microdialysis in Encyclopedia of Sensors C. A. Grimes E. C. Dickey M. V. Pishko Eds. (American Scientific Publishers 2006) vol. 6 pp. 287–312.
Cited by
Martínez‐Sánchez, N., Sweeney, O., Sidarta-Oliveira, D., Caron, A., Stanley, S. A., & Domingos, A. I. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.017 · Cited by 133
Spatiotemporal Metabolic Liver Zonation and Consequences on Pathophysiology
Martini, T., Naef, F., & Tchorz, J. S. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-024831 · Cited by 113
FGF21 reverses MASH through coordinated actions on the CNS and liver
Rose, J. P., Morgan, D. A., Sullivan, A. I., Fu, X., Inigo-Vollmer, M., Burgess, S. C., Meyerholz, D. K., Rahmouni, K., & Potthoff, M. J. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.014 · Cited by 75
The Role of Catecholamines in Pathophysiological Liver Processes
Lelou, E., Corlu, A., Nesseler, N., Rauch, C., Mallédant, Y., Seguin, P., & Aninat, C. (2022) · Cells · doi:10.3390/cells11061021 · Cited by 67
“This innervation has been recently illustrated in elegant works using the immunolabeling-enabled 3D imaging of solvent-cleared organs (iDISCO) technique [1,2].”
BackgroundMethodGilvesy, A., Husén, E., Maglóczky, Z., Mihály, O. S., Hortobágyi, T., Kanatani, S., Heinsen, H., Renier, N., Hökfelt, T. G. M., Mulder, J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02477-6 · Cited by 80
“iDISCO+ volume immunostaining and clearing process were essentially performed as described earlier [3, 78, 79], However, we slightly modified the originally iDISCO+ protocol [78] and applied extended primary/secondary antibody incubations and expanded delipidation time, to compensate the post-mortem effects and high l…”
Method
Metadata
- Authors
- Adori, C., Daraio, T., Kuiper, R., Barde, S., Horvathova, L., Yoshitake, T., Ihnatko, R., Valladolid-Acebes, I., Vercruysse, P., Wellendorf, A. M., Gramignoli, R., Bozoky, B., Kehr, J., Theodorsson, E., Cancelas, J. A., Mravec, B., Jorns, C., Ellis, E., Mulder, J., Uhlén, M., Bark, C., & Hökfelt, T.
- Affiliations
- Department of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.
- Karolinska Institutet (SE)
- Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic.
- Linköping University (SE)
- The Rolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden.
- Cincinnati Children's Hospital Medical Center (US)
- Department of Clinical Pathology/Cytology, Karolinska University Hospital, Huddinge, Sweden.
- Department of Physiology and Pharmacology, Karolinska Institutet, 17177 Stockholm, Sweden.
- Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
- Slovak Academy of Sciences (SK)
- Karolinska University Hospital (SE)
- Science for Life Laboratory (SE)
- Corresponding author
- Uhlén, Mathias
- Bark, Christina
- Hökfelt, Tomas
- ORCID
- Venue
- Science Advances
- Published
- 2021-07-23
- Volume
- 7
- Issue
- 30
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8294768
- OpenAlex
- W3183325670
- Cited by
- 105
- References
- 90
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 22 · 2023: 14 · 2022: 12
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Funders
- Swedish Research Council Formas
- Knut and Alice Wallenberg foundation
- Åhlén-Foundation
- Sven Mattsson’s Foundation
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- non-alcoholic fatty liver disease, axonal sprouting, steatohepatitis, portal hypertension, Vav3, Rac1, hepatic metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging. https://app.cochat.ai/papers/10.1126/sciadv.abg5733
- The paper
- Adori, C., Daraio, T., Kuiper, R., Barde, S., Horvathova, L., Yoshitake, T., Ihnatko, R., Valladolid-Acebes, I., Vercruysse, P., Wellendorf, A. M., Gramignoli, R., Bozoky, B., Kehr, J., Theodorsson, E., Cancelas, J. A., Mravec, B., Jorns, C., Ellis, E., Mulder, J., . . . Hökfelt, T. (2021). Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging. Science Advances. https://doi.org/10.1126/sciadv.abg5733
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.